Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Jul 9, 2019 in Prostate cancer | 0 comments

In a nutshell

This study aimed to investigate a surgical procedure used to treat prostate cancer, retzius sparing laparoscopic robotic-assisted radical prostatectomy (RS-RALP). This study found that RS-RALP had similar side-effects and outcomes to other robotic surgeries.

Some background

Prostate surgery is a treatment option for prostate cancer (PCa). This surgery can be carried out by classic methods (open surgery) or by using special tools, called robotic-assisted laparoscopic radical prostatectomy (RALP). Retzius sparing RALP (RS-RALP) appears to have better continence rates compared to other types of RALPs. Continence is the ability to hold urine without leaking. However, RS-RALP's effectiveness is still unknown.

Methods & findings

This study included 638 patients from 6 clinical trials. 318 patients had RS-RALP and 320 had conventional RALP. Side-effects and tumor free rates after surgery were compared.

RS-RALP was associated with better early continence rates. This was noted at 1 and 3 months after surgery. RS-RALP had similar continence rates to other types of robotic surgeries at 6 and 12 months. It had similar tumor free outcomes to other types of robotic surgery. 

The bottom line

This study found that RS-RALP was associated with good early continence and oncological outcomes.

The fine print

This study is of a low level of evidence. Further studies are needed.

Published By :

World Journal of Urology

Date :

May 14, 2019

Original Title :

Retzius sparing robotic assisted radical prostatectomy vs. conventional robotic assisted radical prostatectomy: a systematic review and meta-analysis.

click here to get personalized updates